A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/05 (2006.01) C07C 229/00 (2006.01) C07C 237/22 (2006.01) C07C 311/19 (2006.01) C07C 323/00 (2006.01) C07D 295/15 (2006.01)
Patent
CA 2322743
Compounds of this invention have the formula: X-(CH2)n-C(O)NH-A-C(COOR5)R3R4 or a pharmaceutically acceptable salt thereof, e.g. formula (1-7) which are useful for inhibiting fibrinogen binding to blood platelets, thereby inhibiting platelet aggregation.
L'invention concerne des composés représentés par la formule X-(CH¿2?)¿n?-C(O)NH-A-C(COOR?5¿)R?3¿R?4¿ ou un sel pharmaceutiquement acceptable de ceux-ci représenté par la formule (1-7). Ces composés sont utiles pour inhiber un fibrogène se liant aux plaquettes sanguines, inhibant de ce fait une agrégation de plaquettes.
Hartman George D.
Meissner Robert S.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1707124